| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $2,080,656 ) |
| 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | R01MH123262 | Synthesizing Best Practice to Accelerate Access to Emerging HIV Prevention Modalities | 000 | 5 | NIH | 2/21/2024 | $601,729 |
| 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | R01DC020764 | Defining the components of olfactory singular expression | 000 | 2 | NIH | 1/10/2024 | $561,915 |
| 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | R21MH135430 | Circuit-level regulation of social avoidance learning in chronically stressed mice | 000 | 1 | NIH | 11/13/2023 | $226,080 |
| 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | R01CA239603 | The Role of the Mutant p53-PARP-MCM Pathway in Triple Negative Breast Cancer | 000 | 5 | NIH | 12/22/2023 | $310,833 |
| 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | R01AG057555 | AI-Powered Quantitative Systems Pharmacology for AD Drug Repurposing | 002 | 7 | NIH | 2/21/2024 | $649,729 |
| 2024 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | 90DPGE0013 | Minority Youth and Centers for Independent Living (MY-CIL) | 01 | 5 | ACL | 2/2/2024 | $0 |
| 2024 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | 90DPGE0013 | Minority Youth and Centers for Independent Living (MY-CIL) | 01 | 5 | ACL | 2/2/2024 | $0 |
| 2024 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | R01AG057555 | AI-Powered Quantitative Systems Pharmacology for AD Drug Repurposing | 001 | 6 | NIH | 2/14/2024 | $178,212 |
| 2024 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | U54CA221704 | (2/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparities Partnership | 000 | 6 | NIH | 10/31/2023 | $0 |
| 2024 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | U54CA221704 | (2/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparities Partnership | 002 | 6 | NIH | 1/24/2024 | $0 |
| 2024 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | R01GM122845 | AI-powered chemical proteomics for drug discovery targeting orphan proteins | 000 | 5 | NIH | 12/20/2023 | $0 |
| 2024 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | 90DPGE0013 | Minority Youth and Centers for Independent Living (MY-CIL) | 01 | 5 | ACL | 2/2/2024 | $0 |
| 2024 | 2022 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | SC2GM135078 | Developing methods and software for fitting the Cox proportional hazards model to partly interval-censored data | 000 | 3 | NIH | 10/16/2023 | $0 |
| 2024 | 2022 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | 90DPGE0013 | Minority Youth and Centers for Independent Living (MY-CIL) | 01 | 5 | ACL | 2/2/2024 | $0 |
| 2024 | 2022 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | 90DPGE0013 | Minority Youth and Centers for Independent Living (MY-CIL) | 01 | 5 | ACL | 2/2/2024 | $0 |
| 2024 | 2022 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | 90DPGE0013 | Minority Youth and Centers for Independent Living (MY-CIL) | 01 | 5 | ACL | 2/2/2024 | $0 |
| 2024 | 2022 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | SC3GM131949 | Diabetes Prevention in Chinese Americans: Online Adaptation of Diabetes Prevention Program | 000 | 4 | NIH | 12/5/2023 | -$23 |
| 2024 | 2022 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | U54CA221704 | (2/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparities Partnership | 001 | 5 | NIH | 1/24/2024 | $0 |
| 2024 | 2022 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | R01AG057555 | AI-Powered Quantitative Systems Pharmacology for AD Drug Repurposing | 000 | 5 | NIH | 2/14/2024 | -$178,212 |
| 2024 | 2022 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | R01MH115835 | Improving Prevention Systems to Reduce Disparities for High Priority Populations. | 000 | 5 | NIH | 2/29/2024 | $0 |
| 2024 | 2021 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | SC3GM127157 | Ajuba, a novel regulator of the ATR response in human cells. | 000 | 4 | NIH | 3/13/2024 | -$3,273 |
| 2024 | 2021 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | T32HL135465 | Hunter-Weill T32 Transdisciplinary Research Training | 000 | 5 | NIH | 1/30/2024 | -$266,334 |
| 2024 | 2020 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | SC1MH091873 | Persistent versus brief suicidal ideation subtypes in risk for adolescent suicide attempts | 000 | 8 | NIH | 1/8/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $15,935,684 ) (Continued on the next page) |
| 2023 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | R25NS080686 | BP-ENDURE at Hunter and NYU | 001 | 14 | NIH | 8/10/2023 | $10,000 |
| 2023 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | R01MH123262 | Synthesizing Best Practice to Accelerate Access to Emerging HIV Prevention Modalities | 000 | 4 | NIH | 2/24/2023 | $678,417 |
| 2023 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | R01CA240963 | Novel Reagents for Rapid and Stable Thiol-Based Bioconjugations | 000 | 5 | NIH | 8/21/2023 | $323,715 |
| 2023 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | U54CA221704 | (2/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparities Partnership | 002 | 6 | NIH | 9/19/2023 | $1,035,402 |
| 2023 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | DP1AT012812 | Charting the evolutionary development of novel genes and the molecular mechanisms of gland tissue organizationin cephalopods | 000 | 1 | NIH | 9/20/2023 | $1,099,000 |
| 2023 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | R01MH118441 | Emotion regulation in the prefrontal - basal forebrain-amygdala circuit | 000 | 5 | NIH | 3/30/2023 | $390,000 |
| 2023 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | R01DA059272 | Couples Motivational Interviewing to reduce drug use and HIV risk in vulnerable male couples | 001 | 1 | NIH | 9/15/2023 | $0 |
| 2023 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | R01DA059272 | Couples Motivational Interviewing to reduce drug use and HIV risk in vulnerable male couples | 000 | 1 | NIH | 9/8/2023 | $734,865 |
| 2023 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | R21CA280595 | Targeting DNA Mismatches for Auger Electron Radiotherapy | 000 | 1 | NIH | 9/8/2023 | $457,607 |
| 2023 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | R01AI175417 | ImmunoPET Probes for the Imaging of Lyme Disease | 000 | 1 | NIH | 9/19/2023 | $565,163 |
| 2023 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | F31CA275343 | HARNESSING IN VIVO CLICK CHEMISTRY FOR 211AT-BASED PRETARGETED RADIOIMMUNOTHERAPY | 000 | 1 | NIH | 9/13/2023 | $32,435 |
| 2023 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | F31CA275343 | HARNESSING IN VIVO CLICK CHEMISTRY FOR 211AT-BASED PRETARGETED RADIOIMMUNOTHERAPY | 001 | 1 | NIH | 9/13/2023 | $0 |
| 2023 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | R36DA058819 | Identifying Transdiagnostic Intervention Targets for PTSD-SUD Comorbidity in a Vulnerable Population: A Mixed-Method Study | 000 | 1 | NIH | 8/31/2023 | $53,743 |
| 2023 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | R21EY035400 | Ultrasonic-tagged remote interferometric flowmetry for brain activity | 000 | 1 | NIH | 8/16/2023 | $224,100 |
| 2023 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | R01GM122845 | AI-powered chemical proteomics for drug discovery targeting orphan proteins | 000 | 5 | NIH | 9/21/2023 | $467,952 |
| 2023 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | R21AG083302 | AI-powered cross-level cross-species omics data integration to elucidate mechanisms of EL | 000 | 1 | NIH | 8/11/2023 | $458,510 |
| 2023 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | K01AG084388 | Caregiving networks of older women living with HIV. | 000 | 1 | NIH | 8/22/2023 | $132,440 |
| 2023 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | R01AG057555 | AI-Powered Quantitative Systems Pharmacology for AD Drug Repurposing | 001 | 6 | NIH | 5/31/2023 | $693,857 |
| 2023 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | T34GM149429 | MARC Program at Hunter College, CUNY | 000 | 1 | NIH | 5/19/2023 | $504,403 |
| 2023 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | R01DC020764 | Defining the components of olfactory singular expression | 000 | 1 | NIH | 2/1/2023 | $608,759 |
| 2023 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | F31CA275334 | Leveraging Metalloinsertors for the PET Imaging and Endoradiotherapy of MMR-Deficient Cancers | 000 | 2 | NIH | 8/3/2023 | $33,176 |
| 2023 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | R01DA050508 | Expanding the potential of couples HIV testing: Adjunct modules to reduce drug use among vulnerable male couples | 001 | 4 | NIH | 5/19/2023 | $1,231,186 |
| 2023 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | R01DA050508 | Expanding the potential of couples HIV testing: Adjunct modules to reduce drug use among vulnerable male couples | 000 | 3 | NIH | 3/30/2023 | $107,596 |
| 2023 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | R01CA239603 | The Role of the Mutant p53-PARP-MCM Pathway in Triple Negative Breast Cancer | 000 | 4 | NIH | 1/31/2023 | $338,463 |
| 2023 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 695 PARK AVE | NEW YORK | NY | 10065-5024 | NEW YORK | USA | R21AG073974 | The effect of Social Isolation on Lexical Retrieval in Elderly Adults | 003 | 3 | NIH | 7/19/2023 | $195,000 |
|